Halberd Corporation (HALB) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Biotecnología industria. La empresa tiene su sede en Jackson Center, PA, United States. El CEO actual es William A. Hartman.
HALB tiene fecha de IPO 2012-09-25, cotiza en el Other OTC, una capitalización de mercado de $484.92K.
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
